Log in to your Inderes Free account to see all free content on this page.
DexTech Medical
10.05 SEK
+2.76 %
Less than 1K followers
DEX
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+2.76 %
-3.37 %
-14.83 %
+9.84 %
+41.55 %
+139.29 %
+163.09 %
-73.20 %
+3.37 %
DexTech Medical operates in biotechnology. The company conducts research and development in the field of urological oncology, where common diseases include prostate cancer. A large part of the research is carried out in collaboration with other international players, research institutes and universities. The largest operations are found in the Nordic market. The company was founded in 2004 and is headquartered in Uppsala.
Read moreMarket cap
185.78M SEK
Turnover
11.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
5.5.
2026
Interim report Q3'26
31.8.
2026
Annual report '26
All
Press releases
ShowingAll content types
DexTech Medical's Myeloma Study (ODX-MM-001), Dose Group 2 and Dose Group 3
DexTech Medical AB, Bulletin from the Annual General Meeting
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio